Palliative treatment of germ cell cancer.

Oing, Christoph; Giannatempo, Patrizia; Honecker, Friedemann; Oechsle, Karin; Bokemeyer, Carsten; Beyer, Jörg (2018). Palliative treatment of germ cell cancer. Cancer treatment reviews, 71, pp. 102-107. Elsevier 10.1016/j.ctrv.2018.10.007

[img]
Preview
Text
2018 Critical Reviews Oing.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (774kB) | Preview

Most patients with metastatic germ-cell cancer (GCC) can be cured by cisplatin-based combination chemotherapy. Yet, about 10-15% of metastatic GCC patients will eventually die of their disease. This narrative review focuses on treatment options when cure is no longer realistic.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology

UniBE Contributor:

Beyer, Jörg

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1532-1967

Publisher:

Elsevier

Language:

English

Submitter:

Rebeka Gerber

Date Deposited:

19 Mar 2019 13:12

Last Modified:

13 Mar 2021 18:32

Publisher DOI:

10.1016/j.ctrv.2018.10.007

PubMed ID:

30415106

Uncontrolled Keywords:

Drug therapy Germ cell cancer Germ cell tumor Palliative treatment Platinum-refractory

BORIS DOI:

10.7892/boris.124931

URI:

https://boris.unibe.ch/id/eprint/124931

Actions (login required)

Edit item Edit item
Provide Feedback